insights_auto
Why is TNXP down 7.10%?
Dive Deeperchevron_right
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
$3.01
arrow_downward
-7.10%(-0.23) 1D
Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
$3.25
High
$3.25
Low
$2.90
Mkt. cap
58.49M
Avg. vol.
1.12M
Volume
1.94M
52-wk high
$20.56
52-wk low
$2.90
EPS
-$12.92
Beta
1.90
Shares outstanding
19.43M
No. of employees
142
Open
$3.25
High
$3.25
Low
$2.90
Mkt. cap
58.49M
Avg. vol.
1.12M
Volume
1.94M
52-wk high
$20.56
52-wk low
$2.90
EPS
-$12.92
Beta
1.90
Shares outstanding
19.43M
No. of employees
142
News stories
From web sources and news partners
BigGo Finance
·
8 hours ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
Benzinga
·
1 hour ago
Dow Jones, Nasdaq 100, and S&P 500 Outlooks: Key Stock Market News This Week
The Motley Fool
·
3 hours ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Traders Union
·
6 hours ago
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersBerkeley Heights, New Jersey, United States
SectorHealth Care
IndustryBiotechnology
Websitetonixpharma.com